Invention Grant
US07935711B2 HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
有权
HIV抑制2-（4-氰基苯基氨基）嘧啶氧化物衍生物
- Patent Title: HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
- Patent Title (中): HIV抑制2-（4-氰基苯基氨基）嘧啶氧化物衍生物
-
Application No.: US11814958Application Date: 2006-02-20
-
Publication No.: US07935711B2Publication Date: 2011-05-03
- Inventor: Herman Augustinus De Kock , Piet Tom Bert Paul Wigerinck
- Applicant: Herman Augustinus De Kock , Piet Tom Bert Paul Wigerinck
- Applicant Address: IE Little Island Co Cork
- Assignee: Tibotec Pharmaceuticals Ltd.
- Current Assignee: Tibotec Pharmaceuticals Ltd.
- Current Assignee Address: IE Little Island Co Cork
- Agency: Patton Boggs LLP
- Priority: EP05101270 20050218
- International Application: PCT/EP2006/060115 WO 20060220
- International Announcement: WO2006/087387 WO 20060824
- Main IPC: C07D239/48
- IPC: C07D239/48 ; A61K31/505
Abstract:
HIV replication inhibitors of formula (I) a pharmaceutically acceptable addition salt; or a stereochemically isomeric form thereof, wherein R1 is halo; R2 and R3 each independently are C1-6alkyl. Pharmaceutical compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.
Public/Granted literature
- US20080194602A1 Hiv Inhibiting 2-(4-Cyanophenylamino) Pyrimidine Oxide Derivatives Public/Granted day:2008-08-14
Information query
